共 165 条
[21]
Dinarvand R(2016)Administrative process and criteria ranking for drug entering health insurance list in Iran-TOPSIS-based consensus model Iran J Pharm Res 15 369-1180
[22]
Haji-Aghajani M(2017)Multiple criteria decision analysis (MCDA) for evaluating new medicines in health technology assessment and beyond: the Advance Value Framework Soc Sci Med 188 137-51
[23]
Malekzadeh R(2017)Multiple criteria decision analysis in the context of health technology assessment: a simulation exercise on metastatic colorectal cancer with multiple stakeholders in the English setting BMC Med Inform Decis Mak 17 149-6
[24]
Sadrolsadat A(2017)Utilization of multiple-criteria decision analysis (MCDA) to support healthcare decision-making FIFARMA, 2016 J Mark Access Health Policy 5 1360545-2389
[25]
Bennett JE(2017)The probabilistic efficiency frontier: a framework for cost-effectiveness analysis in Germany put into practice for hepatitis C treatment options Value Health 20 266-774
[26]
Stevens GA(2018)Assessing the importance of treatment goals in patients with psoriasis: analytic hierarchy process vs. Likert Scales Patient 11 425-34
[27]
Mathers CD(2012)Using the analytic hierarchy process to elicit patient preferences Patient 5 225-1713
[28]
Bonita R(2012)A comparison of analytic hierarchy process and conjoint analysis methods in assessing treatment alternatives for stroke rehabilitation Patient 5 45-970
[29]
Rehm J(2014)Prioritising public health guidance topics in the National Institute for Health and Care Excellence using the Analytic Hierarchy Process Public Health 128 896-52
[30]
Kruk ME(2018)Forecasting incidence of dengue and selecting best method for prevention J Pak Med Assoc 68 1383-264